🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the efficacy of targeted and tailored sequential therapy in ...
Status
Active Not Recruiting
Location
The University of Texas MD Anderson Cancer Center
Start Date
2024-12-30
Trial ID
NCT06664879
Treatments Being Tested
This study is to determine the safety and preliminary efficacy of sabatolim...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-20
Trial ID
NCT05367401
Treatments Being Tested
The main objective of this study was to assess the safety profile of MBG453...
Status
Terminated
Location
Mayo Clinic Arizona
Start Date
2022-03-17
Trial ID
NCT04878432
Treatments Being Tested
The purpose of this study was to investigate the safety, pharmacokinetics a...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-09-26
Trial ID
NCT04097821
Treatments Being Tested
To characterize the safety and tolerability of 1) MBG453 as a single agent ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2017-07-06
Trial ID
NCT03066648
Treatments Being Tested
This was a phase 1b, multi-arm, open-label study of HDM201 in combination w...
Status
Terminated
Location
Duke University Medical Center .
Start Date
2019-06-24
Trial ID
NCT03940352
Treatments Being Tested
This research study is assessing the efficacy of MBG-453, a humanized monoc...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2022-01-27
Trial ID
NCT04823624
Treatments Being Tested
The purpose of the study was to find out if the new drug sabatolimab when g...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-05-31
Trial ID
NCT04812548
Treatments Being Tested
The purpose of this first-in-human study of MBG453 was to characterize the ...
Status
Terminated
Location
Sidney Kimmel CCC At JH Sidney Kimmel CCC
Start Date
2015-11-23
Trial ID
NCT02608268
Treatments Being Tested
This was a Phase III multi-center, randomized, two-arm parallel-group, doub...
Status
Terminated
Location
Yuma Regional Cancer Center
Start Date
2020-06-08
Trial ID
NCT04266301
Treatments Being Tested